Mark Ringhoffer Selected Research

Mark Ringhoffer Research Topics

14	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 07/2003
9	Leukemia 03/2011 - 09/2002
5	Neoplasms (Cancer) 08/2005 - 09/2002
3	Multiple Myeloma 01/2021 - 02/2008
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2015 - 02/2008
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2007 - 09/2002
3	Melanoma (Melanoma, Malignant) 07/2005 - 09/2002
2	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2022 - 12/2016
2	Lymphoma (Lymphomas) 10/2017 - 05/2013
2	Hematologic Neoplasms (Hematological Malignancy) 07/2010 - 08/2005
2	Prostatic Neoplasms (Prostate Cancer) 01/2010 - 09/2009
2	Neoplasm Metastasis (Metastasis) 09/2009 - 09/2002
2	Renal Cell Carcinoma (Grawitz Tumor) 06/2004 - 09/2002
2	Breast Neoplasms (Breast Cancer) 08/2003 - 09/2002
1	Bronchiolitis Obliterans Syndrome 10/2022
1	Infections 01/2019
1	Meningitis 11/2010
1	Lymphatic Metastasis 01/2010
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 09/2009
1	Cap Myopathy 09/2009
1	Residual Neoplasm 01/2007
1	Proteinuria 02/2006
1	Hypertension (High Blood Pressure) 02/2006
1	Anemia 02/2006
1	Myeloid Leukemia (Leukemia, Myelocytic) 08/2003
1	Carcinoma (Carcinomatosis) 09/2002

10	AntigensIBA 09/2009 - 09/2002
5	Hyaluronic Acid (Hyaluronan)IBA 02/2008 - 09/2002
4	Peptides (Polypeptides)IBA 07/2010 - 08/2005
2	midostaurinIBA 01/2022 - 01/2019
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 06/2007 - 08/2005
2	Messenger RNA (mRNA)IBA 02/2004 - 09/2002
1	HLA-G Antigens (HLA G)IBA 10/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2020
1	Dasatinib (BMS 354825)FDA Link 01/2018
1	Core Binding Factors (Core-Binding Factor)IBA 01/2018
1	micaIBA 12/2016
1	Azacitidine (5 Azacytidine)FDA Link 04/2015
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 06/2014
1	Valproic Acid (Depakote)FDA LinkGeneric 06/2014
1	Protein Subunit VaccinesIBA 07/2010
1	AndrogensIBA 01/2010
1	Choline (Choline Chloride)IBA 01/2010
1	trofosfamideIBA 01/2010
1	Docetaxel (Taxotere)FDA Link 01/2010
1	Proteins (Proteins, Gene)FDA Link 09/2009
1	Complementary DNA (cDNA)IBA 09/2009
1	bcr-abl Fusion ProteinsIBA 06/2007
1	Granzymes (Granzyme)IBA 06/2007
1	Imatinib Mesylate (Gleevec)FDA Link 06/2007
1	CreatinineIBA 02/2006
1	VaccinesIBA 08/2005
1	EnzymesIBA 08/2005
1	EpitopesIBA 08/2005
1	HLA-DR Antigens (HLA-DR)IBA 07/2005
1	Myeloblastin (Proteinase 3)IBA 07/2005
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2004
1	Combined VaccinesIBA 02/2004
1	AntibodiesIBA 08/2003
1	Immunoglobulin G (IgG)IBA 08/2003
1	AcidsIBA 09/2002

10	Stem Cell Transplantation 01/2021 - 07/2003
8	Immunotherapy 07/2010 - 09/2002
6	Therapeutics 01/2022 - 09/2002
6	Drug Therapy (Chemotherapy) 01/2022 - 07/2003
4	Hematopoietic Stem Cell Transplantation 10/2022 - 11/2010
1	Cell Transplantation 01/2022
1	Consolidation Chemotherapy 01/2018
1	Salvage Therapy 04/2015
1	Radiotherapy 05/2013